Andrew James King - Exhibit 24 - Power of Attorney Chief Scientific Officer & Head of Research and Development at Aerovate Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Exhibit 24 - Power of Attorney Chief Scientific Officer & Head of Research and Development
Stock Symbol
AVTE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew James King since 5/8/2024

Holdings reported by Andrew James King for Aerovate Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 345K $917K $2.66 Apr 28, 2025 Direct

There are no transactions reported by Andrew James King for Aerovate Therapeutics, Inc.